← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 16, 2018Last known activity
Apr 19, 2023
Acquired by Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. on Oct 28, 2016
Timeline
2010s
- Jun 1, 2014
Klus Pharma Inc.— Founded
- Oct 28, 2016
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.— Acquired By
Drugs by trial phase (5 distinct, 4 trials)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Bile Duct Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Mucoepidermoid
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Cholangiocarcinoma
- Cystadenocarcinoma
- Laryngeal Neoplasms
- Lip Neoplasms
- Mouth Neoplasms
- Neoplasms
- Prostatic Neoplasms
- Rare Diseases
- Rectal Neoplasms
- Salivary Gland Neoplasms
- Stomach Neoplasms
- Tongue Neoplasms
- Tonsillar Neoplasms
- Triple Negative Breast Neoplasms
- Urologic Neoplasms
Recent trials (4)
- NCT05816252Lead sponsorPhase 2Apr 19, 2023
- NCT05642780Lead sponsorPhase 2Dec 23, 2022
- NCT04152499Lead sponsorPhase 1/Phase 2Dec 31, 2019
- NCT03602079Lead sponsorPhase 1/Phase 2Jul 16, 2018
Details
- Founded
- Monmouth Junction, NJ, US Jun 1, 2014
- Last known activity
- Apr 19, 2023